Skip to main content

Table 1 Clinicopathological characteristics in accordance with stromal PD-L1 expression

From: Role of stromal PD-L1 expression in colorectal liver metastasis

Variables

Stromal

PD-L1(-)

(n = 40)

Stromal

PD-L1(+)

(n = 44)

p-value

< Metastatic tumor characteristics >

   

Age (years)

66.6 ± 12.2

65.1 ± 10.4

0.54

Sex (men / women)

30/10

27/17

0.17

Tumor maximum size (cm)

3.5 ± 2.2

3.6 ± 2.0

0.67

Tumor number (< 5 / ≥5)

25/15

32/12

0.33

H-stage (H1 / H2, 3)

23/17

31/13

0.21

Grade (A / B,C)

17/23

27/17

0.08

Metastasis period (synch / meta)

14/26

24/20

0.07

Pre-operative chemotherapy (- / +)

36/4

37/7

0.42

Post-operative chemotherapy (- / +)

10/30

15/29

0.36

Not optimally resectable (- / +)

9/31

19/25

0.04

Tumor PD-L1 expression (- / +)

21/19

14/30

0.05

PD-1 expression (- / +)

31/9

33/11

0.79

HGP (replacement / desmoplastic / pushing)

20/8/12

10/26/8

0.0009

Replacement subtype (- : +)

20/20

34/10

0.008

Desmoplastic subtype (- : +)

32/8

18/26

0.0002

Pushing subtype (- : +)

28/12

36/8

0.20

TILs (low : high)

35/5

33/11

0.14

< Primary tumor characteristics >

   

Tumor differentiation (diff./undiff.)

38/2

43/1

0.67

T (2,3/4)*

34/9

30/8

0.99

Location (colon/rectum)

25/15

20/24

0.12

Lymph node metastasis (-/+)

18/22

20/24

0.97

Venous invasion (-/+)*

15/22

15/26

0.72

Lymphatic invasion (-/+)*

12/25

16/25

0.54

  1. Synch/meta: synchronous/metachronous; diff./undiff.: differentiated histological type/undifferentiated histological type; HGP: histopathological growth pattern
  2. *Data for certain patients were unavailable